These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 30265230

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
    Kim S, Lee M, Shin HJ, Lee J, Suh YL.
    Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952
    [Abstract] [Full Text] [Related]

  • 3. Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease in a Girl: A Rare and Puzzling Diagnosis.
    Ocak S, Bayramoglu Z, Tugcu D, Karaman S, Unuvar A, Karakas Z.
    J Pediatr Hematol Oncol; 2021 Apr 01; 43(3):e375-e379. PubMed ID: 32097280
    [Abstract] [Full Text] [Related]

  • 4. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.
    Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, Néel A, Lifermann F, Villabona C, Graffin B, Hermine O, Rigolet A, Roubille C, Hachulla E, Carmoi T, Bézier M, Meignin V, Conrad M, Marie L, Kostrzewa E, Michot JM, Barete S, Taly V, Cury K, Emile JF, Amoura Z, French Histiocytoses Study Group.
    Blood; 2014 Aug 14; 124(7):1119-26. PubMed ID: 24894769
    [Abstract] [Full Text] [Related]

  • 5. Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
    Diamond EL, Subbiah V, Lockhart AC, Blay JY, Puzanov I, Chau I, Raje NS, Wolf J, Erinjeri JP, Torrisi J, Lacouture M, Elez E, Martínez-Valle F, Durham B, Arcila ME, Ulaner G, Abdel-Wahab O, Pitcher B, Makrutzki M, Riehl T, Baselga J, Hyman DM.
    JAMA Oncol; 2018 Mar 01; 4(3):384-388. PubMed ID: 29188284
    [Abstract] [Full Text] [Related]

  • 6. Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report.
    Yuen CA, Bao S, Aung MS, Shishodia R, Kong XT.
    Per Med; 2024 Mar 01; 21(2):71-78. PubMed ID: 38275171
    [Abstract] [Full Text] [Related]

  • 7. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.
    Picarsic J, Pysher T, Zhou H, Fluchel M, Pettit T, Whitehead M, Surrey LF, Harding B, Goldstein G, Fellig Y, Weintraub M, Mobley BC, Sharples PM, Sulis ML, Diamond EL, Jaffe R, Shekdar K, Santi M.
    Acta Neuropathol Commun; 2019 Nov 04; 7(1):168. PubMed ID: 31685033
    [Abstract] [Full Text] [Related]

  • 8. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF, Haroche J.
    Curr Oncol Rep; 2019 May 21; 21(7):62. PubMed ID: 31115724
    [Abstract] [Full Text] [Related]

  • 9. The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease.
    Dai JW, Lin H, Chang L, Li J, Zhou DB, Cao XX.
    Ann Hematol; 2023 Dec 21; 102(12):3335-3343. PubMed ID: 37922006
    [Abstract] [Full Text] [Related]

  • 10. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
    Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, Cluzel P, Drier A, Hervier B, Benameur N, Besnard S, Donadieu J, Amoura Z.
    Blood; 2013 Feb 28; 121(9):1495-500. PubMed ID: 23258922
    [Abstract] [Full Text] [Related]

  • 11. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
    Johnson WT, Patel P, Hernandez A, Grandinetti LM, Huen AC, Marks S, Ho J, Monaco SE, Jaffe R, Picarsic J.
    J Cutan Pathol; 2016 Mar 28; 43(3):270-5. PubMed ID: 26454140
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P, Antić B, Knezević-Usaj S, Radić-Tasić O, Radovinović-Tasić S, Vasić-Vilić J, Sekulović L, Tarabar O, Tukić L, Jovandić S, Magić Z.
    Vojnosanit Pregl; 2016 Jan 28; 73(1):83-7. PubMed ID: 26964390
    [Abstract] [Full Text] [Related]

  • 13. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
    Milne P, Bigley V, Bacon CM, Néel A, McGovern N, Bomken S, Haniffa M, Diamond EL, Durham BH, Visser J, Hunt D, Gunawardena H, Macheta M, McClain KL, Allen C, Abdel-Wahab O, Collin M.
    Blood; 2017 Jul 13; 130(2):167-175. PubMed ID: 28512190
    [Abstract] [Full Text] [Related]

  • 14. Histopathological and Clinical Findings in Cutaneous Manifestation of Erdheim-Chester Disease and Langerhans Cell Histiocytosis Overlap Syndrome Associated With the BRAFV600E Mutation.
    Liersch J, Carlson JA, Schaller J.
    Am J Dermatopathol; 2017 Jul 13; 39(7):493-503. PubMed ID: 27898473
    [Abstract] [Full Text] [Related]

  • 15. [Status of Langerhans cell histiocytosis in children and adults].
    Kudo K.
    Rinsho Ketsueki; 2019 Jul 13; 60(9):1308-1316. PubMed ID: 31597857
    [Abstract] [Full Text] [Related]

  • 16. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
    Fan X, Liu T, Zhang Z, Sun J, Niu N, Mao C, Wang F, Li J, Zhou D, Cao X, Jin Z, Feng F.
    Eur Radiol; 2023 Nov 13; 33(11):8031-8042. PubMed ID: 37191919
    [Abstract] [Full Text] [Related]

  • 17. Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations.
    Nordmann TM, Juengling FD, Recher M, Berger CT, Kalbermatten D, Wicki A, Paasinen-Sohns A, Cathomas G, Tzankov A, Daikeler T.
    Blood; 2017 Feb 16; 129(7):879-882. PubMed ID: 27940476
    [Abstract] [Full Text] [Related]

  • 18. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
    Haroche J, Cohen-Aubart F, Charlotte F, Maksud P, Grenier PA, Cluzel P, Mathian A, Emile JF, Amoura Z.
    Expert Rev Clin Immunol; 2015 Feb 16; 11(9):1033-42. PubMed ID: 26197238
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults.
    Cao XX, Sun J, Li J, Zhong DR, Niu N, Duan MH, Liang ZY, Zhou DB.
    Ann Hematol; 2016 Apr 16; 95(5):745-50. PubMed ID: 26858028
    [Abstract] [Full Text] [Related]

  • 20. Impact of BRAFV600E mutation on aggressiveness and outcomes in adult clonal histiocytosis.
    Razanamahery J, Godot A, Leguy-Seguin V, Samson M, Audia S, Bonnotte B.
    Front Immunol; 2023 Apr 16; 14():1260193. PubMed ID: 37809108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.